Fresenius Medical Care AG - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING

Ticker Exchange SIC # Website Latest Ticker
FMS New York 7352 www.freseniusmedicalcare.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fresenius Medical Care AG

DaVita Stock Benefits From Strengthening Kidney Care Delivery - Jun 30th, 2026 11:07 am
Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation - Jun 27th, 2026 8:06 pm
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union - Jun 26th, 2026 7:00 am
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate - Jun 25th, 2026 3:20 am
Ottobock Appoints Dr. Katarzyna Mazur-Hofsaess to the Management Board - Jun 24th, 2026 4:02 pm
DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now? - Jun 23rd, 2026 11:17 am
ISG Event to Explore How Enterprises Are Turning AI Investments Into Measurable Business Value - Jun 18th, 2026 3:00 am
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model - Jun 10th, 2026 6:05 am
FMS and Home Dialysis: How 5008X Could Reset Demand - Jun 8th, 2026 12:51 pm
FMS Launches kinexus Digital Platform for Home Dialysis Care - Jun 5th, 2026 9:31 am
DaVita Expands Comprehensive Kidney Care Through Dialysis Services - Jun 4th, 2026 11:41 am
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - Jun 3rd, 2026 11:26 am
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis - Jun 3rd, 2026 6:00 am
Fresenius (FMS) Q1 2026 Earnings Transcript - Jun 1st, 2026 3:28 pm
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness - May 29th, 2026 7:08 am
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million - May 28th, 2026 5:00 am
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 - May 27th, 2026 7:05 am
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months - May 26th, 2026 5:00 am
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care - May 21st, 2026 8:13 am
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer - May 20th, 2026 11:00 am